Answers are grounded in this paper and cite their sources.
This review summarizes an evidence report by the Institute for Clinical and Economic Review on the effectiveness and value of 2 new calcitonin gene-related peptide monoclonal antibody treatments for migraine.
No takes yet. Share an insight, caveat, or question.
Loder et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: